(Q47694971)

4 February 2018

title

Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion (English)

1 reference

4 February 2018

5

Poul Hyttel

1 reference

4 February 2018

author name string

Mandana Haack-Sørensen

1

1 reference

4 February 2018

Susanne Kofoed Hansen

2

1 reference

4 February 2018

Louise Hansen

3

1 reference

4 February 2018

Michael Gaster

4

1 reference

4 February 2018

Annette Ekblond

6

1 reference

4 February 2018

Jens Kastrup

7

1 reference

4 February 2018

publication date

1 February 2013

1 reference

4 February 2018

Stem Cell Reviews and Reports

published in

1 reference

4 February 2018

volume

9

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

44-58

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s12015-012-9386-3

exact match

0 references

cites work

Mesenchymal stromal cell and mononuclear cell therapy in heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Human bone-marrow-derived mesenchymal stem cells: biological characteristics and potential role in therapy of degenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stromal cells for cardiovascular repair: current status and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Stem cells in the treatment of heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stem cells: biology and potential clinical uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Wound therapy by marrow mesenchymal cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Adult mesenchymal stem cells for tissue engineering versus regenerative medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Cell culture medium composition and translational adult bone marrow-derived stem cell research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Effects of plating density and culture time on bone marrow stromal cell characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Replicative senescence of mesenchymal stem cells: a continuous and organized process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

A cellular model system of differentiated human myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Chondrogenic differentiation of mesenchymal progenitor cells encapsulated in ultrahigh-viscosity alginate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Defining the risks of mesenchymal stromal cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Human mesenchymal stromal cells preserve their stem features better when cultured in the Dulbecco's modified Eagle medium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stem cells: cell biology and potential use in therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

In vitro differentiation of size-sieved stem cells into electrically active neural cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Adult bone marrow stromal cells differentiate into neural cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Origin of endothelial progenitors in human postnatal bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Differential regulation of smooth muscle markers in human bone marrow-derived mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Good manufacturing practices production of mesenchymal stem/stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Importance of integrin beta1-mediated cell adhesion on biodegradable polymers under serum depletion in mesenchymal stem cells and chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Cytokine-induced stable neuronal differentiation of human bone marrow mesenchymal stem cells in a serum/feeder cell-free condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Serum free cultured bone marrow mesenchymal stem cells as a platform to characterize the effects of specific molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Serofendic acid, a neuroprotective substance derived from fetal calf serum, inhibits mitochondrial membrane depolarization and caspase-3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Human serum is as efficient as fetal bovine serum in supporting proliferation and differentiation of human multipotent stromal (mesenchymal) stem cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

Ex vivo generation of mature and functional human smooth muscle cells differentiated from skeletal myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-012-9386-3

IL-6 and IL-8 production by human bone marrow stromal cells

21 January 2018

1 reference

12 December 2020

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

12 December 2020

World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects

1 reference

12 December 2020

MSC for the improvement of hematopoietic engraftment

1 reference

12 December 2020

Mesenchymal stem cells

1 reference

12 December 2020

Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?

1 reference

12 December 2020

Prions and orthopedic surgery

1 reference

12 December 2020

Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium

1 reference

12 December 2020

Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction

1 reference

12 December 2020

Isolation and expansion of adipose-derived stem cells for tissue engineering

1 reference

12 December 2020

Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up.

1 reference

12 December 2020

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

1 reference

12 December 2020

Effects of lipid mediators on the synthesis of leukaemia inhibitory factor and interleukin 6 by human bone marrow stromal cells

1 reference

12 December 2020

Extracellular matrix gene expression by human bone marrow stroma and by marrow fibroblasts.

1 reference

12 December 2020

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells

1 reference

12 December 2020

Comparison of mesenchymal stromal cells from young healthy donors and patients with severe chronic coronary artery disease

1 reference

12 December 2020

10.1007/S12015-012-9386-3

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

22644809

1 reference

4 February 2018